Valuation (26%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.28 | -16.73 |
PEG Ratio (TTM) | 0.39 | -5.05 |
P/S Ratio (TTM) | 2,465.37 | 46.48 |
P/B Ratio (TTM) | 2.44 | 28.32 |
P/FCF Ratio (TTM) | -4.02 | -4.22 |
Price to 5YR AVG Earnings Ratio | -3.31 | -5.30 |
Price to 5YR AVG FCF Ratio | -5.60 | -12.41 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -78.19% | -16.10% |
ROE (TTM) | -115.51% | 28.68% |
Net Profit Margin (TTM) | -98,266.67% | -770.56% |
ROIC 5YR AVG | -116.00% | -20.75% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -7.42% | -26.60% | -13.86% |
Revenue | -46.22% | 486.04% | 301.24% |
Net Income | -10.45% | -52.20% | -31.15% |
Cash Flow | -23.41% | -148.77% | -75.74% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.59 | 5.71 |
Quick Ratio (TTM) | 2.59 | 5.49 |
D/E Ratio (TTM) | 0.07 | 0.95 |
Interest Coverage (TTM) | N/A | -6.99 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 12.82 |
LTL to 5YR AVG FCF | -0.02 | 0.13 |
Shares Outstanding Growth 5YR AVG | 10.85% | 41.37% |